Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NINDS

COMPOSITIONS AND METHODS FOR INHIBITING JC VIRUS (JCV)

  • Read more about COMPOSITIONS AND METHODS FOR INHIBITING JC VIRUS (JCV)
US Application 61/879,833
Filed on 2013-09-19

Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS)

  • Read more about Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS)
US Application 61/843,549
Filed on 2013-07-08

Selective Dopamine D2 Receptor Antagonists And Methods Of Their Use

  • Read more about Selective Dopamine D2 Receptor Antagonists And Methods Of Their Use
US Application 61/859,532
Filed on 2013-07-29

OASIS: Automated Brain Lesion Detection Using Cross Sectional Multimodality Magnetic Resonance Imaging

  • Read more about OASIS: Automated Brain Lesion Detection Using Cross Sectional Multimodality Magnetic Resonance Imaging
US Application 61/613,569
Filed on 2012-03-21

DEUTERATED DROXIDOPA DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

  • Read more about DEUTERATED DROXIDOPA DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
US Application 61/669,772
Filed on 2012-07-10

Methods And Compositions For Identifying JC Virus

  • Read more about Methods And Compositions For Identifying JC Virus
US Application 61/661,289
Filed on 2012-06-18

SuBLIME: Automatic Brain Lesion Incidence And Detection Using Multimodality Longitudinal Magnetic Resonance Imaging

  • Read more about SuBLIME: Automatic Brain Lesion Incidence And Detection Using Multimodality Longitudinal Magnetic Resonance Imaging
US Application 61/630,101
Filed on 2011-12-05

Methods of Treating And Preventing Diseses and Disorders of the Central Nervous System

  • Read more about Methods of Treating And Preventing Diseses and Disorders of the Central Nervous System
US Application 61/599,107
Filed on 2012-02-15

USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TRZAT GAUCHER'S DISEASE

  • Read more about USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TRZAT GAUCHER'S DISEASE
US Application 61/561,747
Filed on 2011-11-18

USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT GAUCHER1S DISEASE

  • Read more about USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT GAUCHER1S DISEASE
US Application 61/547,458
Filed on 2011-10-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Next page ››
  • Last page Last »
Subscribe to NINDS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health